128 related articles for article (PubMed ID: 4776565)
21. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm.
Helmer OM; Judson WE
Circulation; 1968 Nov; 38(5):965-76. PubMed ID: 5697693
[No Abstract] [Full Text] [Related]
22. [Induced aldosteronism in hydropic heart insufficiency].
Kaufmann W; Steiner B; Dürr F; Meurer KA; Behn C
Klin Wochenschr; 1969 Jan; 47(1):16-25. PubMed ID: 5381434
[No Abstract] [Full Text] [Related]
23. Aldosterone in cystic fibrosis: measurement in saliva and correlation with disease severity.
Fergusson RJ; Atherden SM; McCrae WM; Edwards CR
Acta Paediatr Scand; 1986 Jan; 75(1):124-7. PubMed ID: 3953268
[TBL] [Abstract][Full Text] [Related]
24. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
[No Abstract] [Full Text] [Related]
25. No adaptation to digitalization as evaluated by digitalis receptor (Na,K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failure.
Schmidt TA; Allen PD; Colucci WS; Marsh JD; Kjeldsen K
Am J Cardiol; 1993 Jan; 71(1):110-4. PubMed ID: 8380532
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
Am J Cardiol; 1996 Oct; 78(8):902-7. PubMed ID: 8888663
[TBL] [Abstract][Full Text] [Related]
27. [The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension].
Orynchak MA
Ter Arkh; 1989; 61(8):17-21. PubMed ID: 2686070
[TBL] [Abstract][Full Text] [Related]
28. Effect of spironolactone on the renal clearance of digoxin in dogs.
O'Brien MS; Salamone LF; Gibson TP
J Pharmacol Exp Ther; 1985 Jul; 234(1):190-4. PubMed ID: 4009501
[TBL] [Abstract][Full Text] [Related]
29. Effects of chronic digoxin treatment on cardiac function, electrolytes, and sarcolemmal ATPase in the canine failing heart due to chronic mitral regurgitation.
Prasad K; O'Neil CL; Bharadwaj B
Am Heart J; 1984 Dec; 108(6):1487-94. PubMed ID: 6095632
[TBL] [Abstract][Full Text] [Related]
30. [Aldosterone and aldosterone antagonists in surgery].
Oelert H
Anaesthesist; 1971 Jun; 20(6):205-11. PubMed ID: 4943021
[No Abstract] [Full Text] [Related]
31. Muscle electrolytes and total exchangeable electrolytes in patients with cardiac diseases.
Valentin N; Olesen KH
Scand J Clin Lab Invest; 1973 Oct; 32(2):161-6. PubMed ID: 4768302
[No Abstract] [Full Text] [Related]
32. Influence of digoxin and diuretic therapy on sweat fluid composition.
Mor A; Benzon L; Aladjem M
Miner Electrolyte Metab; 1985; 11(3):155-7. PubMed ID: 2989675
[TBL] [Abstract][Full Text] [Related]
33. [Erythrocyte electrolyte concentrations as an indicator of digitalis therapy].
Okumura K; Ogawa K; Mizutani K; Kato T; Imai Y; Ito S; Kawamura M
Kokyu To Junkan; 1982 Aug; 30(8):819-24. PubMed ID: 7134689
[No Abstract] [Full Text] [Related]
34. Muzzle secretion electrolytes as a possible indicator of sodium status in buffalo (Bubalus bubalis) calves: effects of sodium depletion and aldosterone administration.
Kumar S; Singh SP
Aust J Biol Sci; 1981; 34(5-6):561-8. PubMed ID: 7340768
[TBL] [Abstract][Full Text] [Related]
35. [Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection].
Daum S; Goerg R; Mack D; Wang D
Prax Klin Pneumol; 1984 Sep; 38(9):406-11. PubMed ID: 6504840
[No Abstract] [Full Text] [Related]
36. Drug therapy of heart disease in pediatric patients. II. The treatment of congestive heart failure in infants and children with digitalis preparations.
Rutkowski MM; Cohen SN; Doyle EF
Am Heart J; 1973 Aug; 86(2):270-5. PubMed ID: 4268965
[No Abstract] [Full Text] [Related]
37. Heart failure.
McKelvie R
Clin Evid; 2004 Jun; (11):122-48. PubMed ID: 15652002
[No Abstract] [Full Text] [Related]
38. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.
Barr CS; Lang CC; Hanson J; Arnott M; Kennedy N; Struthers AD
Am J Cardiol; 1995 Dec; 76(17):1259-65. PubMed ID: 7503007
[TBL] [Abstract][Full Text] [Related]
39. Heart failure.
McKelvie R
Clin Evid; 2004 Dec; (12):115-43. PubMed ID: 15865633
[No Abstract] [Full Text] [Related]
40. [Potassium and sodium content of the blood and muscle tissue and aldosterone excretion in myasthenia].
Kuzin MI; Kuz'min NV; Voĭnova MKh; Kolomenskaia EA
Klin Med (Mosk); 1972 Jan; 50(1):40-4. PubMed ID: 5020028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
